Patients who have undergone gastric resection are at higher risk of developing gastric carcinoma than normal subjects, and bile reflux is believed to play a role in carcinogenesis. An Little is known of the cell kinetics of the gastric corpus mucosa in H pylori gastritis or after gastric resection. This study aimed to measure mucosal cell proliferation in H pylori gastritis affecting the corpus and to compare this with cell proliferation in the gastric corpus after surgical resection.
D A F Lynch, N P Mapstone, A M T Clarke, P Jackson, M F Dixon, P Quirke, A T R Axon Abstract Patients who have undergone gastric resection are at higher risk of developing gastric carcinoma than normal subjects, and bile reflux is believed to play a role in carcinogenesis. An increase in mucosal cell proliferation increases the likelihood of a neoplastic clone of epithelial cells emerging, particularly where there is chronic epithelial injury associated with bile reflux. Helicobacter pylorn is considered a major risk factor for gastric cancer in the intact stomach. It has been shown previously that antral cell proliferation is increased in Hpylori gastritis and falls to normal levels after eradication of the organism. Little is known of corpus cell proliferation in H pylon gastritis or after gastric resection. Using in vitro bromodeoxyuridine labelling of endoscopic biopsy specimens we have found that corpus cell proliferation is increased in Hpylori gastritis. Cell Little is known of the cell kinetics of the gastric corpus mucosa in H pylori gastritis or after gastric resection. This study aimed to measure mucosal cell proliferation in H pylori gastritis affecting the corpus and to compare this with cell proliferation in the gastric corpus after surgical resection.
Methods
Patients undergoing routine diagnostic endoscopy were recruited after they had given informed consent. Those taking H2 antagonists, proton pump inhibitors, non-steroidal anti-inflammatory drugs, antibiotics, or bismuth salts were excluded from the study. At endoscopy, using standard forceps, biopsy specimens were taken from the antrum (2) and corpus (3) of the intact stomach. In patients who had undergone gastric resection, biopsy specimens (3) were taken from a point approximately 5-10 cm from the anastomosis, or 10 cm from the pylorus in the intact resected stomach, on the greater curve. Two biopsy specimens from each site were placed in 10% formalin, routinely processed, and stained with haematoxylin and eosin. A modified Giemsa stain was used to detect H pylori. The third biopsy from the corpus or gastric remnant was taken for in vitro bromodeoxyuridine labelling. Only biopsy specimens of the gastric remnant that were of body type mucosa were included in the study. The study was approved by the hospital ethics committee.
BROMODEOXYURIDINE LABELLING
The corpus/remnant biopsy specimen for immunostaining was put immediately into RPMI 1640 (without L-Glutamine) (Gibco) containing bromodeoxyuridine (5 mg/10 ml), incubated in a waterbath for 60 minutes at 370C, then placed on filter paper and fixed in formalin. Using a three step immunoperoxidase technique, sections were stained with anti-bromodeoxyuridine (DAKOPATT) antibody (1:20 dilution) for 60 minutes. Only sections that were complete and orientated were counted. For the purpose of counting, the gastric mucosa was divided into three zones: zone 1=surface and gastric pit; zone 2 = isthmus; zone 3=gland base. The number of cells to be counted was determined by counting consecutive high power fields until the continuous mean varied by less than 5%. Five hundred cells were found to be necessary. (p=0-002 and p=0.004). The corpus mucosal cell LI% (total and zone 2) was increased in gastric resection patients compared with those with H pylori gastritis (p=0.05 and p=0.02). Subanalysis of patients who had undergone gastric surgery showed that those positive for H pylori had increased mucosal cell total and zone 2 LI% compared with those negative for the organism (p=003 and p=0004). The distribution of the different forms of gastric surgery was similar in the positive (truncal vagotomy and gastroenterostomy (n= 1), polya partial gastrectomy (n=l), Billroth I (n=2), Billroth II (n= 1)), vagotomy and pyloroplasty (n= 1) and negative (truncal vagotomy and pyloroplasty (n= 1), polya partial gastrectomy (n= 1), Billroth I (n=3), Billroth II (n= 1), groups. There was no correlation between patient age and corpus mucosal LI% in controls (R=-0.25; p=0-41), subjects with H pylori gastritis (R=-0.03; p=087), or patients with gastric resection (R=-0.07; p=0.8).
Discussion Epidemiological evidence supports a role for H pylori in gastric carcinogenesis.7-10 We have shown that epithelial cell proliferation in the corpus is increased in H pylori gastritis. This is consistent with our previous finding of increased cell proliferation in the antrum in this condition.1' H pylori damages the gastric mucosa and this leads to a compensatory increase in mucosal proliferation which may expose vulnerable cells to luminal mutagens. Eradication of the organism leads to a reduction in antral mucosal cell proliferation levels to normal."
Bile reflux induces a distinctive histopathological picture which has been termed 'reflux' or 'chemical' gastritis.12 Bile, invariably present after operations that by-pass or destroy the pylorus, is recognised to have cocarcinogenic properties.45 Furthermore, colonisation of the hypochlorhydric resected stomach by bacteria, more characteristic of the faecal flora, leads to the production of nitrosating bacteria which may accelerate the production of carcinogenic N-nitrosocompounds.13 Thus, an increase in gastric mucosal cell permeability caused by bile reflux could expose the epithelial cell nuclei to mutagenic agents present in the lumen of the resected stomach. We have shown that body-type mucosa in the resected stomach has even higher levels of cell proliferation than those found in H pylori gastritis in unoperated individuals.
The finding that H pylori infection of the resected stomach has a synergistic effect on gastric mucosal cell proliferation is. of particular interest. Though bile reflux may inhibit colonisation of the gastric mucosa by H pylori the two often coexist.14 The combination of H pylori and bile reflux seems to cause greater epithelial damage with an increased proliferative response. The presence of these agents together in the intact stomach has a synergistic effect on the development of intestinal metaplasia'4 and is compatible with our findings.
Furthermore, surgical diversion of bile reduces epithelial cell proliferation in the gastric remnant. 15 We have shown that there is no correlation between patient age and mucosal cell proliferation in normal or diseased mucosa. Although the numbers involved are small, we believe that the difference in age distribution between subjects with H pylori associated gastritis and patients with a resected stomach would not account for the difference in mucosal cell proliferation. Other factors such as the underlying morphology of the mucosa,16 inflammatory mediators,'7 or growth regulatory peptides'8 are likely to be important.
In conclusion, corpus mucosal cell proliferation is increased in Hpylori gastritis. Body-type mucosa in the resected stomach has higher proliferation levels than Hpylori gastritis affecting the intact stomach. H pylori positive patients who have undergone resection exhibit a higher LI% than their uninfected counterparts. These data may be explained by synergism between H pylori infection and whatever causes increased cell proliferation in the gastric corpus after gastric surgery. The most likely culprit is bile reflux. These two factors, Hpylori and bile, may be the major players in the development of cancer of the gastric remnant. 
